GlassScriptPhysician profile
Steven B Shamash
NPI 1780841312
$9,647.35
in general payments reported to CMS, 2019-2025
21 companies · $683 in 2025
The $683 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,693 · 2020: $1,883 · 2021: $2,127 · 2022: $553 · 2023: $699 · 2024: $2,011 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435 · Travel and Lodging: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,435.08 |
| Travel and Lodging | $957.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $6,171.11 | 2019-2025 | |
| Stryker Corporation | $749.89 | 2019-2023 | Variax |
| Depuy Synthes Sales INC. | $491.93 | 2021-2025 | Na, Va-Lcp, Healix Knotless Peek |
| Skeletal Dynamics INC | $326.00 | 2021 | |
| Endo USA, INC. | $267.41 | 2024-2025 | Xiaflex |
| Arthrex, INC. | $262.65 | 2024 | |
| Zimmer Biomet Holdings, INC. | $262.42 | 2020-2021 | |
| Acumed LLC | $188.87 | 2024 | Nanophix Implant, Innate Implant, Inframe Implant |
| Royal Biologics, INC. | $166.78 | 2020 | |
| Nuvasive Specialized Orthopedics, INC. | $162.18 | 2019 | |
| Arteriocyte Medical Systems, INC. | $140.68 | 2024 | Magellan |
| Axogen | $140.23 | 2019-2023 | Avance Nerve Graft |
| Lifenet Health | $97.47 | 2019 | |
| Microport Orthopedics INC | $54.88 | 2023 | Mpo Hip System |
| Exsomed Corporation | $39.45 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $32.77 | 2024 | Cerament G, Ceramentbone Void Filler |
| Endo Pharmaceuticals INC. | $30.30 | 2021-2023 | Xiaflex |
| Fidia Pharma USA INC. | $19.57 | 2024 | Hyalgan, Triluron, Hymovis |
| Ferring Pharmaceuticals INC. | $17.00 | 2023 | Euflexxa |
| Horizon Therapeutics Plc | $14.44 | 2020 | |
| Merck Sharp & Dohme LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Shamash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.